Final Report of the Cosmetic Ingredient Review Expert Panel Amended Safety Assessment of Calendula officinalis-Derived Cosmetic Ingredients

被引:33
作者
Andersen, F. Alan [1 ]
Bergfeld, Wilma F. [1 ]
Belsito, Donald V. [1 ]
Hill, Ronald A. [1 ]
Klaassen, Curtis D. [1 ]
Liebler, Daniel C. [1 ]
Marks, James G., Jr. [1 ]
Shank, Ronald C. [1 ]
Slaga, Thomas J. [1 ]
Snyder, Paul W. [1 ]
机构
[1] Cosmet Ingredient Rev, Washington, DC 20036 USA
关键词
safety; cosmetics; calendula; COMPOSITAE PLANTS; QUERCETIN; GENOTOXICITY; PERFORMANCE; DERMATITIS; EXTRACTS;
D O I
10.1177/1091581810384883
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Calendula officinalis extract, C officinalis flower, C officinalis flower extract, C officinalis flower oil, and C officinalis seed oil are cosmetic ingredients derived from C officinalis. These ingredients may contain minerals, carbohydrates, lipids, phenolic acids, flavonoids, tannins, coumarins, sterols and steroids, monoterpenes, sesquiterpenes, triterpenes, tocopherols, quinones, amino acids, and resins. These ingredients were not significantly toxic in single-dose oral studies using animals. The absence of reproductive/developmental toxicity was inferred from repeat-dose studies of coriander oil, with a similar composition. Overall, these ingredients were not genotoxic. They also were not irritating, sensitizing, or photosensitizing in animal or clinical tests but may be mild ocular irritants. The Cosmetic Ingredient Review (CIR) Expert Panel concluded that these ingredients are safe for use in cosmetics in the practices of use and concentration given in this amended safety assessment.
引用
收藏
页码:221S / 243S
页数:23
相关论文
共 79 条
[2]  
[Anonymous], 2001, INT J TOXICOL, V20, P13
[3]  
[Anonymous], 1993, IARC MONOGRAPHS EVAL, V58
[4]  
[Anonymous], 2003, INT J TOXICOL S3, V22, P1
[5]  
[Anonymous], 2008, INT COSMETIC INGREDI
[6]  
[Anonymous], COSMET TOILET
[7]  
[Anonymous], 2004, INT J TOXICOL S2, V23, P23
[8]  
AVRAMOVA S, 1988, MED BIOL INF, V4, P28
[9]   The safety assessment of fragrance materials [J].
Bickers, DR ;
Calow, P ;
Greim, HA ;
Hanifin, JM ;
Rogers, AE ;
Saurat, JH ;
Sipes, IG ;
Smith, RL ;
Tagami, H .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2003, 37 (02) :218-273
[10]  
*BIOL, 1997, AC EYE IRR PRIM UNPU, P6